UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000013354
Receipt number R000015582
Scientific Title Randomized phase II study of carboplatin + paclitaxel + bevacizumab or cisplatin + pemetrexed + bevacizumab in patients with previously untreated locally advanced or metastatic non-squamous non-small cell lung cancer (CLEAR study)
Date of disclosure of the study information 2014/03/06
Last modified on 2021/08/17 10:10:45

No. Disposal Last modified on Item of update
1 Insert 2014/03/06 15:13:59
2 Update 2014/03/06 17:43:38 Key exclusion criteria
3 Update 2014/03/06 17:46:14 Last name of contact person
Institute
Institute
4 Update 2014/05/01 11:42:36 Key exclusion criteria
Key exclusion criteria
5 Update 2014/09/11 11:57:36 Classification by specialty
6 Update 2015/03/10 15:06:02 Institutions
7 Update 2015/03/10 15:11:42 Institute
Institute
8 Update 2016/09/06 09:12:53 Interventions/Control_1
Interventions/Control_2
Key exclusion criteria
9 Update 2016/09/06 09:14:39 Division name
Name of primary person or sponsor
Organization
10 Update 2016/09/12 18:17:23 Recruitment status
11 Update 2018/03/12 10:11:25 UMIN ID1
12 Update 2018/03/12 10:14:43 Last follow-up date
13 Update 2019/08/26 18:02:27 Recruitment status
Date of IRB
14 Update 2021/08/17 09:54:06 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Email
Name of primary person or sponsor
Organization
Organization
Address
Address
Tel
Email
15 Update 2021/08/17 10:10:03 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
16 Update 2021/08/17 10:10:45 Recruitment status